As of 2025-09-18, the EV/EBITDA ratio of MEI Pharma Inc (MEIP) is -5.51. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. MEIP's latest enterprise value is 119.75 mil USD. MEIP's TTM EBITDA according to its financial statements is -21.71 mil USD. Dividing these 2 quantities gives us the above MEIP EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 12.6x - 15.5x | 14.5x |
| Forward P/E multiples | 16.7x - 24.1x | 18.5x |
| Fair Price | (5.52) - 8.70 | 0.16 |
| Upside | -279.9% - 183.3% | -94.7% |
| Date | EV/EBITDA |
| 2025-09-17 | -4.55 |
| 2025-09-16 | -4.72 |
| 2025-09-15 | -5.18 |
| 2025-09-12 | -5.22 |
| 2025-09-11 | -5.72 |
| 2025-09-10 | -5.51 |
| 2025-09-09 | -4.90 |
| 2025-09-08 | -5.37 |
| 2025-09-05 | -7.95 |
| 2025-09-04 | -8.04 |
| 2025-09-03 | -8.59 |
| 2025-09-02 | -9.26 |
| 2025-08-29 | -9.28 |
| 2025-08-28 | -9.99 |
| 2025-08-27 | -9.91 |
| 2025-08-26 | -10.16 |
| 2025-08-25 | -9.57 |
| 2025-08-22 | -9.51 |
| 2025-08-21 | -8.77 |
| 2025-08-20 | -8.71 |
| 2025-08-19 | -8.90 |
| 2025-08-18 | -9.32 |
| 2025-08-15 | -9.34 |
| 2025-08-14 | -9.36 |
| 2025-08-13 | -9.87 |
| 2025-08-12 | -9.13 |
| 2025-08-11 | -9.22 |
| 2025-08-08 | -9.97 |
| 2025-08-07 | -9.78 |
| 2025-08-06 | -9.53 |
| 2025-08-05 | -9.68 |
| 2025-08-04 | -9.83 |
| 2025-08-01 | -9.30 |
| 2025-07-31 | -9.89 |
| 2025-07-30 | -9.68 |
| 2025-07-29 | -9.68 |
| 2025-07-28 | -11.57 |
| 2025-07-25 | -13.23 |
| 2025-07-24 | -12.94 |
| 2025-07-23 | -12.10 |
| 2025-07-22 | -13.49 |
| 2025-07-21 | -12.83 |
| 2025-07-18 | -11.51 |
| 2025-07-17 | -8.52 |
| 2025-07-16 | -7.18 |
| 2025-07-15 | -5.51 |
| 2025-07-14 | -5.24 |
| 2025-07-11 | -4.72 |
| 2025-07-10 | -4.72 |
| 2025-07-09 | -4.84 |